WILLIAM MCCLENDON: Open Payments
NPI 1790735652 · PASCAGOULA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,882 in 101 payments from 23 companies in 2025. Trend: 2023 $1,976 · 2024 $2,155 · 2025 $1,882
Food & beverage: $1,882
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $220 |
| Novo Nordisk Inc | 11 | $159 |
| AstraZeneca Pharmaceuticals LP | 9 | $153 |
| Amgen Inc. | 10 | $148 |
| Sumitomo Pharma America, Inc. | 8 | $146 |
| Janssen Pharmaceuticals, Inc | 6 | $129 |
| Lilly USA, LLC | 8 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $97 |
| Lundbeck LLC | 4 | $88 |
| PFIZER INC. | 4 | $87 |
Products named: REXULTI, GEMTESA, SPRAVATO, JARDIANCE, MOUNJARO, OTEZLA, AIRSUPRA, Korlym.
Industry payments across MS — which companies pay providers there.
